Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Software Platform Integrates Tumor Imaging Metrics Core Measurement Capabilities for Clinical Cancer Trials

By HospiMedica International staff writers
Posted on 06 Dec 2012
A new software development platform allows users to easily build specialized plug-ins to extend the functionality of their products. More...
Because the platform provides all the required image visualization and management services, developers can focus on the specifics of their particular core competencies.

ClearCanvas, Inc. (Toronto, Canada), a medical imaging informatics company, announced the roll-out of the integration between the ClearCanvas open source picture archiving and communication system (PACS) and workstation and the Tumor Imaging Metrics Core (TIMC; Boston, MA, USA) clinical trials system developed at Massachusetts General Hospital (Boston, MA, USA) for use in managing clinical trials across multiple institutions.

“We could not find off-the-shelf commercial software that met our requirements, so we decided to build custom tools designed to our own specifications for making protocol-driven measurements for cancer clinical trials and to electronically link these measurements and images to the web-based workflow management and reporting system that we developed for our Tumor Imaging Metrics Core,” said Gordon J. Harris, PhD, codirector of TIMC. “By creating plug-in software modules within an open source radiology imaging environment, we were able to build our own custom-designed measurement tools and upload results directly to our web-based tracking system to create a comprehensive and integrated solution that can serve as a common platform across multiple cancer centers.”

Dr. Harris reported that with an integrated system that manages all facets of clinical trials measurements, the TIMC has been able to provide efficient and effective tumor measurements, with fast turnaround time, across many hospitals. TIMC, which is used by hospitals comprising the Dana-Farber/Harvard Cancer Center (Boston, MA, USA), can offer improved quality tumor metrics for oncologists, with disruption and effort for oncology coordinators and radiologists, helping ensure that patients are suitably qualified for participation criteria in clinical trials.

“We are very excited about what the TIMC has done,” said Norman Young, CEO of ClearCanvas. “This integration has demonstrated exactly what the ClearCanvas platform is intended for. It has enabled a team of innovators to quickly and easily build and integrate new specialized tools without worrying about building the PACS to host them, saving time and resources.”

ClearCanvas is a worldwide provider of novel medical imaging solutions, including diagnostic workstations, PACS, and radiology information systems (RIS) integrated with a range of sophisticated partner applications that support specific workflows.

Related Links:

ClearCanvas
Tumor Imaging Metrics Core
Massachusetts General Hospital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.